Connective tissue growth factor was found to be overexpressed in mammary tumours, pancreatic cancer, sarcoma cancers, prostate cancers (Yang et al, 2005) and gliomas (Yin et al, 2010). Here, CCN2 is linked to Familial prostate cancer.